US : AbbVie Inc. - ABBV | IMGN Deal Makes Good Strategic Sense: Strengthens Hem/Onc Biz, Enhances...
⬆ $Abbvie Inc(ABBV)$ - ABBV announced proposed acquisition of ImmunoGen (IMGN) for ~$10.1B ($9.8B net of cash), an oncology-based biotech with a focus on Antibody-Drug...
Continue reading on Smartkarma:- https://www.smartkarma.com/insights/us-abbvie-inc-abbv-imgn-deal-makes-good-strategic-sense-strengthens-hem-onc-biz-enhances-lt-growth-profile?utm_source=tiger_community
By CGS CIMB Research, Insight Provider on Smartkarma:- https://www.smartkarma.com/profiles/cgs-cimb-research?utm_source=tiger_community
On Abbvie Inc (ABBV):- https://www.smartkarma.com/entities/abbvie-inc?utm_source=tiger_community
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。